Agios Pharmaceuticals (STU:8AP) Net Interest Margin (Bank Only) %


STU:8AP Agios Pharmaceuticals Inc STU:8AP
48 GF Score
Price €32.40
GF Value €73.52
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Agios Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:8AP
48GF Score
Agios Pharmaceuticals Inc STU:8AP
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Agios Pharmaceuticals (STU:8AP) Overvalued in 2026?

Based on GuruFocus' analysis, Agios Pharmaceuticals stock appears to be undervalued. The current stock price of €32.40 is trading 55.9% below its estimated GF Value™ of €73.52. GuruFocus considers Agios Pharmaceuticals to be Possible Value Trap.

Key valuation signals for STU:8AP:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €73.52 vs. price of €32.40 (55.9% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the STU:8AP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agios Pharmaceuticals Business Description

Other Exchanges AGIO:USA0HB0:UK
Address 88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
48GF Score

Get the complete analysis for STU:8AP

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.40
Price
€73.52
GF Value